120-46-7
基本信息
1,3-二苯基-1,3-丙二酮
1,3-二苯基丙二酮
ω-苯甲酰基苯乙酮
二苯甲酰甲烷
二苯甲醯甲烷
二苯甲酰基甲烷, 98+%
1,3-diphenylpropane-1,3-dione
DBM
DIBENZOYLMETHANE
,3-Diphenyl-propane-1,3-dione
1,3-Diphenyl-1,3-propanediamine
1,3-diphenyl-3-propanedione
1,3-Diphenylpropanedione
2-Benzoylacetophenone
3-Propanedione,1,3-diphenyl-1
arenzu dk 2
-Benzoylacetophenone
-Benzoylace-tophenone
Dibenzoylmethan
hodiastab 83
-Hydroxy-chalkone
karenzudk2
omega-Benzoylacetophenone
Phenyl phenacyl ketone
Phenyl-hydroxystyrylketone
物理化学性质
外观 | 白色、浅黄色结晶性粉末。 |
外观性状 | 无色斜方形片状结晶。熔点81℃,沸点219℃(2.4kPa)。易溶于氯醇、氯仿,能溶于氢氧化钠溶液,不溶于碳酸钠溶液,极微溶于水。 |
熔点 | 77-79 °C(lit.) |
沸点 | 219-221 °C18 mm Hg(lit.) |
密度 | 0.800 g/cm3 |
蒸气压 | 0.01Pa at 20℃ |
折射率 | 1.6600 (estimate) |
闪点 | 219-221°C/18mm |
储存条件 | Store at RT. |
溶解度 | 可溶于氯仿(轻微)、甲醇(轻微、超声处理) |
酸度系数(pKa) | 8.95±0.10(Predicted) |
形态 | Crystals |
颜色 | 淡黄色至黄色 |
水溶解性 | It is Soluble in ether, chloroform, and aqueous sodium hydroxide. Insoluble in water. |
Merck | 14,3009 |
BRN | 514910 |
稳定性 | 稳定的。与强氧化剂不相容。 |
InChIKey | NZZIMKJIVMHWJC-UHFFFAOYSA-N |
CAS 数据库 | 120-46-7(CAS DataBase Reference) |
NIST化学物质信息 | 1,3-Propanedione, 1,3-diphenyl-(120-46-7) |
EPA化学物质信息 | 1,3-Propanedione, 1,3-diphenyl- (120-46-7) |
安全数据
危险性符号(GHS) | GHS07 |
警示词 | 警告 |
危险性描述 | H315-H319-H335 |
防范说明 | P261-P271-P280 |
危险品标志 | Xi |
危险类别码 | R36/37/38 |
安全说明 | S22-S24/25 |
WGK Germany | 3 |
RTECS号 | TZ1930000 |
Hazard Note | Irritant |
TSCA | Yes |
海关编码 | 29143900 |
应用领域
制备方法
图谱信息
二苯甲酰基甲烷(120-46-7)质谱(MS)二苯甲酰基甲烷(120-46-7)核磁图(1HNMR)二苯甲酰基甲烷(120-46-7)核磁图(13CNMR)二苯甲酰基甲烷(120-46-7)红外图谱(IR1)二苯甲酰基甲烷(120-46-7)红外图谱(IR2)二苯甲酰基甲烷(120-46-7)红外图谱(IR3)二苯甲酰基甲烷(120-46-7)Raman光谱知名试剂公司产品信息
Dibenzoylmethane, 98%(120-46-7) Acros Organics
二苯甲酰基甲烷价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2024/11/08 | A13450 | 1,3-二苯基-1,3-丙二酮, 98+% 1,3-Diphenyl-1,3-propanedione, 98+% | 120-46-7 | 25g | 409元 |
2024/11/08 | A13450 | 1,3-二苯基-1,3-丙二酮, 98+% 1,3-Diphenyl-1,3-propanedione, 98+% | 120-46-7 | 100g | 1244元 |
2024/11/08 | A13450 | 1,3-二苯基-1,3-丙二酮, 98+% 1,3-Diphenyl-1,3-propanedione, 98+% | 120-46-7 | 500g | 4969元 |
常见问题列表
Dibenzoylmethane (10, 20, 30, 40, 50 μM; 6 hours) treatment concentration-dependently increases the mRNA level of HO-1 but has no effect on the mRNA level of Nrf2 in HepG2 cells. Dibenzoylmethane induces HO-1 and Nrf2 protein expression, and the induction diminishes after 12 h.
Dibenzoylmethane (10, 20, 30, 40, 50 μM; 2 hours) concentration-dependently increases the phosphorylated protein levels of Erk1/2, p38MAPK, JNK, AMPK, and Akt in HepG2 cells.
Dibenzoylmethane does not show significant cytotoxicity.
Dibenzoylmethane (200, 500 mg/kg/day; ip; for three consecutive days) pretreatment significantly reduces both the area and the severity of necrosis, as well as the leukocyte infiltration, at a dose of 200 mg/kg in wild-type and Nrf2 knockout mice.
Dibenzoylmethane protectes against CCl4-induced (1:49,v/v, 10 ml/kg) liver damage in wild-type mice.